Blue Trust Inc’s Cue Health Inc. Common Stock HLTH Stock Holding History

Blue Trust Inc’s Portfolio HLTH Stock Details HLTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-52	Closed	–	–	2789
2023 Q4	$0	Buy	+52	New	+$17	﹤0.01%	2735

Other funds holding HLTH

Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return

Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

JPC

Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Blue Trust Inc's HLTH Position: Q1 2024 in Review

Blue Trust Inc sold out of Cue Health Inc. Common Stock (HLTH) in Q1 2024, closing a stake of 52 shares.

Blue Trust Inc first reported a position in HLTH in Q4 2023 and held it in 1 quarter. The position peaked at $0 in Q4 2023. 57 funds tracked by Wall St. Rank hold HLTH as of Q1 2024.

Blue Trust Inc reported no remaining Cue Health Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Blue Trust Inc sold 52 Cue Health Inc. Common Stock shares in Q1 2024.
Blue Trust Inc first reported a position in Cue Health Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Blue Trust Inc's Cue Health Inc. Common Stock position peaked at $0 in Q4 2023.
57 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q1 2024.

Based on Blue Trust Inc's 13F filing for Q1 2024, filed 1 May 2024.